CLINICAL_TRIALS
trial_result
· 2018-11-02
Clinical Trial Update: Recombinant Interferon Alfa-2b in Treating Patients With Melanoma [NA]
Summary
Clinical trial update for recombinant interferon alfa-2b in melanoma shows completed status with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: William Carson | Conditions: Stage IA Skin Melanoma, Stage IB Skin Melanoma | NA | Status: COMPLETED | Results posted: 2018-11-02